Highlights and Quick Summary
- EBIT Margin for the quarter ending June 30, 2022 was -8.53% (a -11.97% decrease compared to previous quarter)
- Year-over-year quarterly EBIT Margin decreased by -359.27%
- Annual EBIT Margin for 2021 was -24.2% (a 99.01% increase from previous year)
- Annual EBIT Margin for 2020 was -12.16% (a -120.11% decrease from previous year)
- Annual EBIT Margin for 2019 was 60.46% (a 46.71% increase from previous year)
- Twelve month EBIT Margin ending June 30, 2022 was -9.73% (a 566.44% increase compared to previous quarter)
- Twelve month trailing EBIT Margin increased by 126.28% year-over-year
Trailing EBIT Margin for the last four month:
30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
---|---|---|---|
-9.73% | -1.46% | 1.77% | -4.3% |
Visit stockrow.com/ANIK
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBIT Margin of Anika Therapeutics Inc.
Most recent EBIT Marginof ANIK including historical data for past 10 years.Interactive Chart of EBIT Margin of Anika Therapeutics Inc.
Anika Therapeutics Inc. EBIT Margin for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | -8.53% | -9.69% | – | – | – |
2021 | -25.47% | 3.29% | 24.07% | 3.67% | -24.2% |
2020 | -54.92% | -25.01% | -31.08% | 20.04% | -12.16% |
2019 | 16.13% | 40.57% | 39.17% | 22.17% | 60.46% |
2018 | 36.21% | 32.0% | 36.81% | -36.83% | 41.21% |
2017 | 33.1% | 37.78% | 52.97% | 34.23% | 80.64% |
2016 | 44.35% | 53.08% | 50.67% | 48.06% | 48.95% |
2015 | 55.24% | 55.47% | 54.27% | 35.46% | 51.76% |
2014 | 51.98% | 46.64% | 57.86% | 70.19% | 58.19% |
2013 | 49.08% | 43.74% | 45.12% | 32.87% | 43.43% |
2012 | 34.47% | 18.47% | 31.26% | 21.33% | 27.63% |
2011 | 26.65% | 26.1% | – | – | 21.56% |
Business Profile of Anika Therapeutics Inc.
Sector: Healthcare
Industry: Medical Devices